Austin Ho

Mar 7, 2024 | onlinelibrary.wiley.com | Richard Bennett |Eric Li |Austin Ho |Jonathan Aguiar

1 INTRODUCTION Prostate-specific membrane antigen (PSMA) based imaging with positron emission tomography (PET) agents has emerged as a superior method of imaging for initial staging for newly diagnosed prostate cancer (PCa) and for evaluation of biochemical recurrence (BCR).1-3 PSMA scans were first approved by the Food and Drug Administration (FDA) for use in December 2020.

Jan 18, 2024 | medium.com | Austin Ho

I stumbled across The Residency after my friend Santiago and I were discussing how there was a lack of opportunities for young entrepreneurs to be able to focus solely on building and developing the skills necessary to take their companies from 0 to 1.